Sarepta’s stock slammed after patient dies of liver failure. Here’s what Wall Street is saying.
Source: MarketWatch | Published: March 18, 2025, 3:40 p.m.
More than 800 people have been treated with Elevidys, the only approved treatment for Duchenne muscular dystrophy, the company said.
Read Original Article
Back to News List